## Clinical Diagnosis: Delirium Tremens (DTs) ### Diagnostic Criteria Recognition The patient presents with the **classic tetrad of delirium tremens**: | Feature | Present in This Case | |---------|----------------------| | **Autonomic hyperactivity** | HR 128, BP 162/104, fever 38.5°C, diaphoresis | | **Visual/tactile hallucinations** | Insects crawling on skin (tactile) | | **Disorientation & confusion** | Acute mental status change | | **Tremor** | Implied by restlessness; often present | | **Timing** | 36 hours post-last drink (peak onset 48–96 hrs) | **High-Yield:** DTs is the **most severe form of alcohol withdrawal** and represents a medical emergency with mortality of 15–20% if untreated. ### Pathophysiology 1. **Chronic alcohol** → chronic GABA~A~ receptor downregulation and glutamate upregulation 2. **Abrupt cessation** → loss of GABA inhibition + unopposed glutamate excitation 3. **Result:** Severe CNS hyperexcitability, autonomic storm, and hallucinations **Key Point:** The hallucinations in DTs are typically **visual or tactile** (not auditory), and patients retain insight that they are hallucinations (unlike psychosis). The fever is due to hypermetabolism and sympathetic overdrive, not infection. ### Immediate Management Algorithm ```mermaid flowchart TD A["Suspected Delirium Tremens<br/>(Autonomic + Hallucinations + Confusion<br/>36-96 hrs post-cessation)"]:::outcome A --> B{"Confirm diagnosis<br/>& rule out mimics"}:::decision B -->|"Vital signs, mental status,<br/>labs (glucose, Mg, Ca, PO4),<br/>CT head if trauma history"| C["Confirmed DTs"]:::outcome C --> D["Lorazepam 2-4 mg IV<br/>q 5-10 min until calm<br/>+ Thiamine 100 mg IV"]:::action D --> E["ICU admission<br/>Continuous monitoring"]:::action E --> F["Supportive care:<br/>Correct electrolytes,<br/>Fluid resuscitation,<br/>Nutritional support"]:::action F --> G["Prevent relapse:<br/>Counseling, rehabilitation,<br/>Naltrexone/Acamprosate"]:::action ``` ### Benzodiazepine Dosing in DTs **Clinical Pearl:** Lorazepam dosing in severe withdrawal is **higher and more frequent** than in early withdrawal: - **Early withdrawal:** 1–2 mg IV q 5–10 min PRN - **DTs/severe withdrawal:** 2–4 mg IV q 5–10 min until patient is calm, then q 30 min–1 hr - **Goal:** Suppress tremor, reduce hallucinations, normalize vital signs - **Monitoring:** Continuous pulse oximetry, cardiac monitoring, frequent vital signs - **ICU level care** is mandatory because of seizure risk and respiratory depression from benzodiazepines ### Why This Is NOT Sepsis or Intracranial Injury **Sepsis differential:** While post-operative infection is possible, the **temporal relationship** (36 hours post-last drink, not post-operative day 2) and **hallucination pattern** (tactile, not delirium from infection) point to withdrawal. Blood cultures and antibiotics would be delayed and inappropriate without fever source. **Intracranial injury:** CT head is reasonable given trauma history, but the **classic DTs presentation** (autonomic + tactile hallucinations + confusion in known alcoholic) makes withdrawal diagnosis far more likely. CT should not delay benzodiazepine administration. ### Thiamine and Electrolyte Correction **High-Yield:** Always give **thiamine 100 mg IV before or with dextrose** to prevent Wernicke encephalopathy. Correct: - **Magnesium** (hypomagnesemia worsens withdrawal and seizure risk) - **Potassium** (hypokalemia increases arrhythmia risk in autonomic storm) - **Phosphate** (hypophosphatemia impairs ATP production) ### Prognosis and Follow-Up - **Mortality of untreated DTs:** 15–20% - **Mortality with treatment:** <5% - **Recovery:** Usually 3–7 days with supportive care - **Long-term:** Rehabilitation, psychosocial support, pharmacotherapy (naltrexone, acamprosate, disulfiram) for relapse prevention
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.